FINWIRES · TerminalLIVE
FINWIRES

ASX:PEB

10 stories mentioning ASX:PEB

Every FINWIRES story that references ASX:PEB, newest first.

Asia

New Zealand Shares Fall; Napier Port Holdings Completes Share Repurchase Program

New Zealand shares ended lower on Wednesday despite a rise in most Asian shares.The S&P/NZX 50 Index fell 0.42%, or 55.63 points, to close at 13,115.08.Investors looked past geopolitical tensions to focus on the tech sector. Citing people familiar with the matter, Reuters reported that SpaceX is targeting a $1.75 trillion valuation in its initial public offering."The [tech sector] trend remains positive, with the catalyst for further material gains possible with a resolution with Iran," said veteran strategist Louis Navellier, as quoted by Bloomberg.In domestic news, New Zealand's seasonally adjusted new dwellings consents rose 11% to 3,802 in April from 3,429 in the previous month, according to Stats NZ dataAlso, a total of 14,364 metric tonnes (MT) of products were sold during the Global Dairy Trade (GDT) auction held on Tuesday, with supply ranging from 13,601 to 17,661 MT, according to data from the trading platform.Further, New Zealand recorded two-way international trade of NZ$60.9 billion for the March quarter, up 6.3% from a year earlier as both exports and imports increased, according to Stats NZ data.Meanwhile, the national average asking price for property in New Zealand remained nearly flat in May, down just 0.2% year over year to NZ$862,518, realestate.co.nz said.Finally, there are signs of gradual improvement in New Zealand's credit landscape despite a challenging environment, although the recovery remains uneven across products, regions, and sectors, Centrix said in its May Credit Indicator report.In corporate news, Napier Port Holdings (NZE:NPH) completed an on-market share buyback program launched in May, purchasing a total of 312,000 ordinary shares.Pacific Edge (NZE:PEB, ASX:PEB) completed its NZ$36.1 million equity raising at NZ$0.17 per share, comprising a NZ$25.4 million placement and an oversubscribed retail offer that drew NZ$46 million in applications.

^NZ50ASX:PEBNZE:NPHNZE:PEB
Asia

Pacific Edge Completes Over NZ$36 Million Equity Raise; Shares Tumble 5%

Pacific Edge (NZE:PEB, ASX:PEB) completed its NZ$36.1 million equity raising at NZ$0.17 per share, comprising a NZ$25.4 million placement and an oversubscribed retail offer that drew NZ$46 million in applications, with NZ$10.7 million accepted, according to a Wednesday Australia and New Zealand bourse filing.The company raised NZ$10.2 million through a share purchase plan and a further NZ$500,000 under placement capacity from the retail proceeds, per the filing.The company will issue 62.7 million new shares under the retail offer, expected to be allotted and to commence trading on the New Zealand Exchange on Thursday, ranking equally with existing ordinary shares, the filing added.The company's Kiwi shares tumbled 5% in recent Wednesday trade.

ASX:PEBNZE:PEB
Asia

New Zealand Shares Flat; Radius Residential Care Expands Debt Facilities by NZ$30 Million

New Zealand shares ended flat with a negative bias on Monday, amid a fall in oil prices on hopes of a resolution of the conflict in the Middle East.The S&P/NZX 50 Index was little changed to close at 12,970.28.Brent crude oil futures fell over ​4% to $98.83 per barrel. US President Donald Trump said he had told ​his representatives not to rush into any deal with Iran. Earlier, the President said the US and Iran had "largely negotiated" a memorandum of understanding on a deal to reopen the critical Strait of Hormuz.In corporate news, Radius Residential Care (NZE:RAD) restructured and expanded its bank debt facilities with a new lending syndicate comprising Commonwealth Bank of Australia's ASB Bank and the Bank of China New Zealand, increasing its available funding by NZ$30 million.Pacific Edge (ASX:PEB, NZE:PEB) reported a fiscal year 2026 loss of NZ$0.038 per share, compared with NZ$0.037 a year earlier. Operating revenue for the 12 months ended March 31 was NZ$11.5 million, compared with NZ$21.8 million a year earlier.Eroad (ASX:ERD, NZE:ERD) reported that it swung to a loss of NZ$0.8582 per share in the fiscal 2026 from a profit of NZ$0.0073 a year earlier. Revenue for the 12 months ended March 31 was NZ$195.2 million, compared with NZ$194.4 million a year earlier.

^NZ50ASX:PEBNZE:PEBNZE:RAD
Asia

Pacific Edge Posts Wider Fiscal 2026 Loss, Lower Revenue

Pacific Edge (ASX:PEB, NZE:PEB) reported Monday fiscal 2026 loss of NZ$0.038 per share, compared with NZ$0.037 a year earlier.Analysts polled by FactSet expected loss of NZ$0.05.Operating revenue for the 12 months ended March 31 was NZ$11.5 million, compared with NZ$21.8 million a year earlier. Analysts surveyed by FactSet expected NZ$12.5 million.

ASX:PEBNZE:PEB
Asia

Pacific Edge Secures Medicare Local Draft Coverage Determination for Cxbladder Tests for Hematuria, Shares Hit Three-Year High

Pacific Edge (ASX:PEB, NZE:PEB) said a draft local coverage determination (LCD) establishing hematuria evaluation as a covered Medicare benefit has been published, with explicit coding guidance for its Cxbladder Triage and Triage Plus tests, according to a Friday Australia and New Zealand bourse filing.The company said the draft LCD distinguishes hematuria patients as eligible for Cxbladder Triage and Triage Plus, contrasting with an existing non-coverage LCD for patients with cancer or substantiated suspicion of cancer."The draft LCD and LCA confirm our position as the first mover and market leader in non-invasive diagnostics for microhematuria patients suspected of bladder cancer, and Pacific Edge now stands on the cusp of a major commercial inflection point with the only two tests covered for microhematuria evaluation," said Chief Executive Peter Meintjes.While an LCD, when finalized, directly enables reimbursement for over 66 million Medicare patients, the company said the draft coverage language also provides a template for US commercial payers covering 223 million patients, with the news expected to provide a tailwind to international market adoption, the filing added.The draft LCD begins a notice and comment period of at least 45 days, with Novitas, a Medicare administrative contractor, required to publish a final version or withdraw the draft within 12 months, with the LCD becoming effective 45 days after finalization, it added.The company's New Zealand shares rose 40% in recent Friday trade, their highest since May 2023.

ASX:PEBNZE:PEB
Asia

Pacific Edge Launches NZ$6 Million Retail Share Offer; Shares Up 4%

Pacific Edge (ASX:PEB, NZE:PEB) launched a retail share offer aimed at eligible existing shareholders to raise up to NZ$6 million, with provision to accept oversubscriptions, according to a Thursday filing with the Australian and New Zealand bourses.Eligible shareholders may apply for up to NZ$50,000 worth of new shares at an issue price of NZ$0.17 per share, per the filing.The funds will be used to provide the company with additional resources and capacity to support ongoing operations and growth, assist in achieving Medicare re-coverage, and continue advancing evidence generation, product development, and innovation, the filing added.The company's New Zealand shares rose around 4% in recent Thursday trade.

ASX:PEBNZE:PEB
Asia

New Zealand Shares Flat; NZX Appoints Acting CFO

New Zealand shares ended flat with a negative bias on Wednesday after a lower Wall Street close impacted by a hotter-than-expected US inflation report.The S&P/NZX 50 Index was little changed to close at 13,063.06.On Tuesday, the Nasdaq Composite fell 0.7%, the S&P 500 dropped 0.2%, while the Dow Jones managed to add 0.11%.The US Consumer Price Index gained 3.8% year on year in April, data from the Bureau of Labor Statistics showed.New Zealand will maintain tight control over day-to-day spending in this year's budget while boosting capital investment to improve infrastructure, defense, and energy security, according to a Wednesday Reuters report, citing Prime Minister Christopher Luxon's speech on Wednesday.In domestic news, Expectations for New Zealand's one-year-ahead annual consumer price index (CPI) inflation increased by 82 basis points to 3.41% from 2.59% in the June quarter, according to the Reserve Bank of New Zealand's (RBNZ) survey.Also, high-frequency data pointed to slowing momentum across services industries and households in New Zealand as the conflict in the Middle East leaves global oil markets tight, and shipping costs and refining margins elevated, ANZ said in its Quarterly Economic Outlook report.Further, the outlook for New Zealand's economy has shifted now to another year of "positive but still sub-par growth" at 1.5% in the wake of the conflict in the Middle East, due to which oil and refined fuel prices have risen, with real petrol and diesel prices now at a 50-year high, Westpac said.Meanwhile, a total of 3,019 metric tonnes (MT) of products were sold during the Global Dairy Trade (GDT) pulse auction held Tuesday, with supply ranging from 2,700 MT to 3,050 MT, according to data from the trading platform.In corporate news, NZX (NZE:NZX) appointed Deputy Chief Financial Officer Amy Trotman as acting CFO, effective immediately.Pacific Edge (ASX:PEB, NZE:PEB) secured NZ$25.4 million through an oversubscribed share placement priced at NZ$0.17 apiece, representing a 2.3% discount to the closing price on May 8.

^NZ50ASX:PEBNZE:NZXNZE:PEB
Asia

Pacific Edge Secures Over NZ$25 Million in Oversubscribed Share Placement

Pacific Edge (ASX:PEB, NZE:PEB) secured NZ$25.4 million through an oversubscribed share placement priced at NZ$0.17 apiece, representing a 2.3% discount to the closing price on May 8, according to a Wednesday filing with the New Zealand bourse.The placement received strong support from institutional and other existing investors, prompting directors to expand the offer size and accept oversubscriptions due to high demand, per the filing.The company also intends to offer eligible existing shareholders a retail placement to raise up to an additional NZ$6 million at the same price, with the option to accept oversubscriptions at its discretion, the filing said.The funds will be used to strengthen the company's operations and growth capacity, support Medicare re-coverage, and advance evidence generation, product development, and innovation, the filing added.

ASX:PEBNZE:PEB
Asia Markets

New Zealand Shares Rise; Pacific Edge Launches NZ$24 Million Capital Raise

New Zealand shares ended marginally higher on Monday amid investors' worries of a prolonged US-Iran conflict.The S&P/NZX 50 Index rose 0.27% or 35.35 points to close at 13,210.48.US President Donald Trump rejected Iran's response to a US peace proposal, sending oil prices sharply higher on Monday, as fears grew that the conflict would continue and keep shipping through the Strait of Hormuz at a standstill, according to a Monday Reuters report.Brent oil price rose to about $105 per barrel in recent Monday trade.In domestic news, supplier costs for food supermarkets in New Zealand rose 2% on average in April from a year earlier, marking a continued slowdown in the pace of increases from recent months, Infometrics said in a report.In corporate news, Pacific Edge (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share.Chorus' (NZE:CNU, ASX:CNU) website showed internet outages impacting parts of New Zealand early on Monday, concentrated in and around the Auckland area.

^NZ50ASX:CNUASX:PEBNZE:CNUNZE:PEB
Asia

Pacific Edge Launches NZ$24 Million Capital Raise

Pacific Edge (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determination that may restore coverage for Cxbladder Triage tests and enhance revenue potential and commercial payer adoption.

ASX:PEBNZE:PEB